What is the intrinsic value of 1110.HK?

As of 2025-07-15, the Intrinsic Value of Kingworld Medicines Group Ltd (1110.HK) is 1.63 HKD. This 1110.HK valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.53 HKD, the upside of Kingworld Medicines Group Ltd is 207.80%.

The range of the Intrinsic Value is 1.23 - 2.38 HKD

Is 1110.HK undervalued or overvalued?

Based on its market price of 0.53 HKD and our intrinsic valuation, Kingworld Medicines Group Ltd (1110.HK) is undervalued by 207.80%.

	Range	Selected	Upside
a
DCF (Growth 5y)	1.23 - 2.38	1.63	207.8%
DCF (Growth 10y)	1.42 - 2.68	1.87	252.0%
DCF (EBITDA 5y)	1.40 - 2.17	1.80	240.0%
DCF (EBITDA 10y)	1.61 - 2.57	2.08	292.0%
Fair Value	1.83 - 1.83	1.83	244.82%
P/E	0.82 - 1.17	0.96	81.4%
EV/EBITDA	0.65 - 1.75	1.03	93.6%
EPV	0.02 - 0.17	0.09	-82.4%
DDM - Stable	0.36 - 0.89	0.63	18.4%
DDM - Multi	0.62 - 1.34	0.87	63.3%